Skip to main content

Peer Review reports

From: Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells

Original Submission
9 Dec 2016 Submitted Original manuscript
11 Feb 2017 Author responded Author comments - Gerke Ariaans
3 Jan 2017 Reviewed Reviewer Report - Samuel Kerk
4 Jan 2017 Reviewed Reviewer Report - Jamunarani Veeraraghavan
Resubmission - Version 2
11 Feb 2017 Submitted Manuscript version 2
16 Mar 2017 Author responded Author comments - Gerke Ariaans
16 Feb 2017 Reviewed Reviewer Report - Samuel Kerk
2 Mar 2017 Reviewed Reviewer Report - Jamunarani Veeraraghavan
Resubmission - Version 3
16 Mar 2017 Submitted Manuscript version 3
Publishing
24 Mar 2017 Editorially accepted
29 Mar 2017 Article published 10.1186/s12885-017-3230-8

You can find further information about peer review here.

Back to article page
\